UBS Group AG - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 17 filers reported holding XENON PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$200,929
+7.0%
5,882
+20.6%
0.00%
Q2 2023$187,842
+13.8%
4,879
+5.7%
0.00%
Q1 2023$165,135
-10.2%
4,614
-1.0%
0.00%
Q4 2022$183,822
+49.4%
4,662
+36.1%
0.00%
Q3 2022$123,000
+61.8%
3,426
+38.6%
0.00%
Q2 2022$76,000
+100.0%
2,472
+102.1%
0.00%
Q1 2022$38,000
-32.1%
1,223
-31.2%
0.00%
Q4 2021$56,000
+250.0%
1,777
+73.9%
0.00%
Q3 2021$16,000
-15.8%
1,022
+0.1%
0.00%
Q2 2021$19,000
+5.6%
1,021
+2.1%
0.00%
Q1 2021$18,000
-33.3%
1,000
-41.9%
0.00%
Q4 2020$27,000
+22.7%
1,722
-13.3%
0.00%
Q3 2020$22,000
-24.1%
1,986
-12.7%
0.00%
Q2 2020$29,000
+314.3%
2,274
+259.8%
0.00%
Q1 2020$7,000
-69.6%
632
-63.9%
0.00%
Q4 2019$23,000
+109.1%
1,753
+42.4%
0.00%
Q3 2019$11,000
-78.4%
1,231
-76.0%
0.00%
Q2 2019$51,000
+70.0%
5,123
+70.8%
0.00%
Q1 2019$30,000
+2900.0%
3,000
+1913.4%
0.00%
Q4 2018$1,000
-90.9%
149
-82.6%
0.00%
Q3 2018$11,000
+37.5%
854
-3.9%
0.00%
Q2 2018$8,0000.0%889
-64.9%
0.00%
Q2 2017$8,000
+60.0%
2,530
+310.0%
0.00%
Q3 2016$5,000
-37.5%
617
-44.2%
0.00%
Q1 2016$8,000
-61.9%
1,106
-57.9%
0.00%
Q4 2015$21,000
+75.0%
2,629
+148.5%
0.00%
Q2 2015$12,000
+100.0%
1,058
+205.8%
0.00%
Q1 2015$6,000
-14.3%
346
-7.0%
0.00%
Q4 2014$7,0003720.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders